If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Company Board Changes

16 Jul 2024 10:49

RNS Number : 6025W
Mandarin Oriental International Ltd
16 July 2024
 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

 

COMPANY BOARD CHANGES

 

 

Mandarin Oriental International Limited (the 'Company') is pleased to announce the following changes to the Board:

 

Fabrice Megarbane will join the Board of the Company as an Independent Non-Executive Director with effect from 1 August 2024.

 

John Witt, Group Managing Director of Jardine Matheson, will step down as a Director from the Company's Board and as a member of the Remuneration and Nominations Committees. Adam Keswick will step down from the Nominations Committee and Graham Baker will step down from the Remuneration Committee. Adam remains as a Director. These changes will all take effect from 22 July 2024.

 

The Company is also announcing that Sean Ward will be appointed as Company Secretary, with effect from 22 July 2024, succeeding Jonathan Lloyd.

 

Fabrice Megarbane is the Chief Global Growth Officer of L'Oréal. He was previously President and CEO of L'Oréal North Asia and CEO of L'Oréal China and serves on its global executive committee. He managed a combined revenue of more than EUR10 billion, which accounts for over 25 percent of L'Oréal's global business, and an organisation of 20,000 people. Fabrice started his marketing career at L'Oréal S.A. in 2000. He brings multi-market experience, combining emerging and developed markets, including Europe, the Middle East, Africa, Germany, China and now North Asia.

 

Commenting on these changes, Chair Ben Keswick said: "I am pleased to welcome Fabrice to our Board, which will benefit from his extensive experience at L'Oréal. He is an accomplished and passionate marketer and brand builder with a deep consumer focus and extensive experience in digital transformation.

 

We will continue to enhance the composition of our Board, bringing in relevant expertise to help our management team deliver on their strategy and build long-term shareholder value.

 

I would also like to thank John and Jonathan for their service to the Board."

 

 

Jonathan Lloyd, Jardine Matheson LimitedFor and on behalf of Mandarin Oriental International Limited

 

16th July 2024

 

www.mandarinoriental.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUBCMUPCUBQ
Date   Source Headline
14th May 201812:08 pmRNSDirector/PDMR Shareholding
11th May 201810:12 amRNSDirector Declaration
9th May 20182:47 pmRNSDirectorate Change
9th May 20182:34 pmRNSNon-Routine Resolutions submitted via NSM
9th May 20182:19 pmRNSResult of AGM
9th May 201812:32 pmRNSInterim Management Statement
3rd May 201811:03 amRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSDirector/PDMR Shareholding
2nd May 201810:34 amRNSDividend
30th Apr 201810:54 amRNSTotal Voting Rights
25th Apr 201810:51 amRNSDirector/PDMR Shareholding
12th Apr 201810:49 amRNSAnnual Financial Report
29th Mar 201810:28 amRNSTotal Voting Rights
26th Mar 201810:34 amRNSBlock listing Interim Review
19th Mar 201811:11 amRNSDirector/PDMR Shareholding
14th Mar 20187:38 amRNSAdditional Listing
12th Mar 20189:16 amRNSDirector/PDMR Shareholding
8th Mar 20189:07 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
7th Feb 20189:14 amRNSNotice of 2017 Final Results
31st Jan 201810:33 amRNSTotal Voting Rights
16th Jan 201810:07 amRNSDirector/PDMR Shareholding
27th Dec 20179:39 amRNSDirector/PDMR Shareholding
21st Dec 201710:06 amRNSDirector/PDMR Shareholding
1st Dec 20179:58 amRNSDirector/PDMR Shareholding
30th Nov 20179:21 amRNSDirector/PDMR Shareholding
30th Nov 20179:17 amRNSTotal Voting Rights
31st Oct 20179:12 amRNSTotal Voting Rights
25th Oct 201711:15 amRNSDirector/PDMR Shareholding
4th Oct 201710:11 amRNSDividend
3rd Oct 201711:25 amRNSDirector/PDMR Shareholding
29th Sep 201711:09 amRNSDirector/PDMR Shareholding
27th Sep 20177:31 amRNSUpdate Review:Long-term Strategic Options for EXHK
25th Sep 201710:14 amRNSBlock listing Interim Review
15th Sep 201710:11 amRNSMO-Review of Long-term Strategic Options for EXHK
3rd Aug 201710:06 amRNSHalf Yearly Results
6th Jul 201710:15 amRNSNotice of 2017 Half-Yearly Results
5th Jun 20177:00 amRNSMO to Review Long-term Strategic Options for EXHK
3rd May 20172:13 pmRNSNon-Routine Resolutions submitted via NSM
3rd May 20172:01 pmRNSResult of AGM
3rd May 201712:35 pmRNSInterim Management Statement
28th Apr 201710:10 amRNSTotal Voting Rights
26th Apr 201710:40 amRNSDividend
5th Apr 201710:16 amRNSAnnual Financial Report
31st Mar 201710:42 amRNSTotal Voting Rights
27th Mar 201710:13 amRNSBlock listing Interim Review
27th Mar 201710:10 amRNSDirector/PDMR Shareholding
14th Mar 201711:04 amRNSDirector/PDMR Shareholding
3rd Mar 20178:06 amRNSAdditional Listing
2nd Mar 20179:06 amRNS2016 PRELIMINARY ANNOUNCEMENT OF RESULTS
1st Feb 20179:40 amRNSNotice of 2016 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.